In continuation of my update on RNAi
Short strands of nucleic acids, called small RNAs, can be used for  targeted gene silencing, making them attractive drug candidates. These  small RNAs block gene expression  through multiple RNA interference (RNAi) pathways, including two newly  discovered pathways in which small RNAs bind to Argonaute proteins or  other forms of RNA present in the cell nucleus, such as long non-coding  RNAs and pre-mRNA. 
Keith T. Gagnon, PhD, and David R. Corey, PhD,  University of Texas Southwestern Medical Center, in Dallas, review  common features shared by RNAi pathways for controlling gene expression  and focus in detail on the potential for Argonaute-RNA complexes in gene  regulation and other exciting new options for targeting emerging forms  of non-coding RNAs and pre-mRNAs in the article "Argonaute and the  Nuclear RNAs: New Pathways for RNA Mediated Control of Gene Expression." 
Ref : http://www.liebertpub.com/global/pressrelease/new-rna-based-therapeutic-strategies-for-controlling-gene-expression/987/"The field of RNA mediated control of gene expression is rapidly evolving and the article by Gagnon and Corey provides a highly informative and up to date review of this exciting and often surprising area of biomedical research. We are delighted to publish this important review for the field," says Co-Editor-in-Chief Bruce A. Sullenger, PhD, Duke Translational Research Institute, Duke University Medical Center, Durham, NC.


